{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:13:57Z","timestamp":1789179237471,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ymgme.2022.02.007","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T21:08:21Z","timestamp":1645218501000},"page":"164-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Inborn errors of purine and pyrimidine metabolism: A guide to diagnosis"],"prefix":"10.1016","volume":"136","author":[{"given":"Agnieszka","family":"Jurecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tylki-Szymanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2022.02.007_bb0005","first-page":"171","article-title":"Defects in metabolism of purines and pyrimidines","volume":"24","author":"Van Gennip","year":"1999","journal-title":"Ned. Tijdsch. Klin. Chem."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10545-009-1094-z","article-title":"Inborn errors of purine and pyrimidine metabolism","volume":"32","author":"Jurecka","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0025-6196(11)63590-8","article-title":"Hereditary disorders of purine and pyrimidine metabolism: identification of their biochemical phenotypes in the clinical laboratory","volume":"72","author":"Valik","year":"1997","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1023\/A:1005308923168","article-title":"When to investigate for purine and pyrimidine disorders. Introduction and review of clinical and laboratory indications","volume":"20","author":"Simmonds","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01880664","article-title":"When and how does one search for inborn errors of purine and pyrimidine metabolism?","volume":"16","author":"Simmonds","year":"1994","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0030","series-title":"Inherited Metabolic Defects","first-page":"215","article-title":"Inborn errors of pyrimidine metabolism","author":"Simmonds","year":"2000"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0035","series-title":"Physicians Guide to the Laboratory Diagnosis of Metabolic Diseases","article-title":"Purine and pyrimidine disorders","author":"Simmonds","year":"2003"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00005792-200103000-00003","article-title":"The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families","volume":"80","author":"Puig","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ymgme.2008.04.013","article-title":"Clinical, biochemical and molecular findings in seven polish patients with adenylosuccinate lyase deficiency","volume":"94","author":"Jurecka","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/0-306-46843-3_46","article-title":"Defects of pyrimidine degradation: clinical, molecular and diagnostic aspects","volume":"486","author":"van Gennip","year":"2000","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1005356806329","article-title":"Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects","volume":"20","author":"van Gennip","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00008711","article-title":"Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency","volume":"104","author":"Van Kuilenburg","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0065","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/B978-0-444-59565-2.00052-6","article-title":"Metabolic disorders of purine metabolism affecting the nervous system","volume":"113","author":"Jinnah","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0070","series-title":"Inherited Metabolic Diseases","author":"Hoffmann","year":"2017"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.siny.2003.10.004","article-title":"Perimortem laboratory investigation of genetic metabolic disorders","volume":"9","author":"Christodoulou","year":"2004","journal-title":"Semin. Neonatol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0080","series-title":"Physician\u2019s Guide to the Diagnosis, Treatment, and Follow-Up or Inherited Metabolic Diseases","author":"Bierau","year":"2014"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0085","first-page":"6","article-title":"Diagnosis and early management of inborn errors of metabolism presenting around the time of birth","volume":"95","author":"Leonard","year":"2006","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpeds.2006.09.027","article-title":"Lethal fetal and early neonatal presentation of adenylosuccinate lyase deficiency: observation of 6 patients in 4 families","volume":"150","author":"Mouchegh","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0095","first-page":"1323","article-title":"Differential diagnosis of cerebral palsy: Lesch-Nyhan syndrome without self-mutilation","volume":"130","author":"Mitchell","year":"1984","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0100","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1542\/peds.102.6.e69","article-title":"Inborn errors of metabolism in infancy: a guide to diagnosis","volume":"102","author":"Burton","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.640371","article-title":"Metabolic Seizures","volume":"12","author":"Almannai","year":"2021","journal-title":"Front. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2022.02.007_bb0110","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/0883073899014001011","article-title":"Diagnostic approach to metabolic encephalopathies","volume":"14","author":"De Vivo","year":"1999","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0115","series-title":"A Clinical Guide to Inherited Metabolic Diseases","author":"JTR","year":"2005"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10545-014-9755-y","article-title":"Adenylosuccinate lyase deficiency","volume":"38","author":"Jurecka","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/0883073811424465","article-title":"Neurologic presentation, diagnostics, and therapeutic insights in a severe case of adenylosuccinate lyase deficiency","volume":"27","author":"Jurecka","year":"2012","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00431-011-1503-9","article-title":"Magnetic resonance imaging of the brain in adenylosuccinate lyase deficiency: a report of seven cases and a review of the literature","volume":"171","author":"Jurecka","year":"2012","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1528-1167.2006.00391.x","article-title":"Beta-ureidopropionase deficiency presenting with febrile status epilepticus","volume":"47","author":"Assmann","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0140","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41436-020-0933-z","article-title":"Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation","volume":"22","author":"Rymen","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fneur.2020.00064","article-title":"A patient with CAD deficiency responsive to uridine and literature review","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0150","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1093\/hmg\/ddv057","article-title":"Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors","volume":"24","author":"Ng","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0155","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/brain\/awl056","article-title":"Lesch-Nyhan disease international study, delineation of the motor disorder of Lesch-Nyhan disease","volume":"129","author":"Jinnah","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0160","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2512","article-title":"Purines and pyrimidines","author":"Scriver","year":"2001"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0012162205001374","article-title":"Behavioral aspects of Lesch-Nyhan disease and its variants","volume":"47","author":"Schretlen","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0170","first-page":"50","article-title":"Attenuated adenylosuccinate lyase deficiency: a report of one case and a review of the literature","volume":"45","author":"Jurecka","year":"2014","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0175","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10545-014-9742-3","article-title":"Inborn errors of pyrimidine metabolism: clinical update and therapy","volume":"37","author":"Balasubramaniam","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0180","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ng751","article-title":"Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy","volume":"29","author":"Saada","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0185","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/01.WNL.0000028689.93049.9A","article-title":"Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA","volume":"59","author":"Mancuso","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0190","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/archneur.63.8.1122","article-title":"Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene","volume":"63","author":"Oskoui","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00861588","article-title":"Gout, uric acid and purine metabolism in paediatric nephrology","volume":"7","author":"Cameron","year":"1993","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0200","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000030458","article-title":"Xanthine stone in the urinary bladder of a male child","volume":"63","author":"Kiss","year":"1999","journal-title":"Urol. Int."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2022.02.007_bb0205","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1007\/s10545-009-9011-z","article-title":"Xanthine dehydrogenase deficiency with novel sequence variations presenting as rheumatoid arthritis in a 78-year-old patient","volume":"33","author":"Jurecka","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0210","first-page":"447","article-title":"HPRT deficiency as the cause of ESRD in a 24-year-old patient: a very rare presentation of the disorder","volume":"18","author":"Kassimatis","year":"2005","journal-title":"J. Nephrol."},{"issue":"Pt 3","key":"10.1016\/j.ymgme.2022.02.007_bb0215","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/bj3290477","article-title":"Analysis of abnormalities in purine metabolism leading to gout and to neurological dysfunctions in man","volume":"329","author":"Curto","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0220","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s004670050466","article-title":"Presymptomatic detection of familial juvenile hyperuricaemic nephropathy in children","volume":"12","author":"McBride","year":"1998","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0225","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2169\/internalmedicine.37.905","article-title":"Partial hypoxanthine phosphoribosyltransferase deficiency: unrecognized until adult ages","volume":"37","author":"Kamatani","year":"1998","journal-title":"Intern. Med."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0230","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","article-title":"Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity","volume":"2","author":"Giblett","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1005300621350","article-title":"Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency","volume":"20","author":"Hershfield","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0240","series-title":"Inborn Metabolic Diseases","article-title":"Disorders of purine and pyrimidine metabolism","author":"van den Berghe","year":"2006"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0245","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1172-2-48","article-title":"Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome","volume":"2","author":"Torres","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0250","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/03630268008997736","article-title":"Erythrocyte disorders of purine and pyrimidine metabolism","volume":"4","author":"Valentine","year":"1980","journal-title":"Hemoglobin"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0255","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pediatrneurol.2010.06.007","article-title":"Adenylosuccinate lyase deficiency in the United Kingdom pediatric population: first three cases","volume":"43","author":"Lundy","year":"2010","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0260","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/jmg.39.6.440","article-title":"Towards a suggestive facial dysmorphism in adenylosuccinate lyase deficiency?","volume":"39","author":"Holder-Espinasse","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ejhg.2008.174","article-title":"Misleading behavioural phenotype with adenylosuccinate lyase deficiency","volume":"17","author":"Gitiaux","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0270","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/jimd.12274","article-title":"AICA-ribosiduria due to ATIC deficiency: delineation of the phenotype with three novel cases, and long-term update on the first case","volume":"43","author":"Ramond","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0275","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ng.499","article-title":"Exome sequencing identifies the cause of a mendelian disorder","volume":"42","author":"Ng","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0280","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ajo.2005.05.027","article-title":"Phenotypic characterization of a large family with RP10 autosomal-dominant retinitis pigmentosa: an Asp226Asn mutation in the IMPDH1 gene","volume":"140","author":"Kozma","year":"2005","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0285","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/13816810500229090","article-title":"Clinical phenotype in a Swedish family with a mutation in the IMPDH1 gene","volume":"26","author":"Schatz","year":"2005","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0290","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1167\/iovs.04-1197","article-title":"Screen of the IMPDH1 gene among patients with dominant retinitis pigmentosa and clinical features associated with the most common mutation, Asp226Asn","volume":"46","author":"Wada","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1871525715666170529091921","article-title":"Thiopurine S-methyltransferase as a Pharmacogenetic biomarker: significance of testing and review of major methods","volume":"15","author":"Asadov","year":"2017","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0300","first-page":"4363","article-title":"van Gennip, Dihydropyrimidinase deficiency and severe 5-fluorouracil toxicity","volume":"9","author":"van Kuilenburg","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0305","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejca.2003.12.004","article-title":"Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil","volume":"40","author":"van Kuilenburg","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0310","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6600208","article-title":"Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene","volume":"86","author":"Maring","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0315","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/clpt.2013.172","article-title":"Clinical pharmacogenetics implementation consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing","volume":"94","author":"Caudle","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0320","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ijc.10599","article-title":"Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS14+1g>a mutation","volume":"101","author":"Van Kuilenburg","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0325","first-page":"4705","article-title":"Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene","volume":"6","author":"van Kuilenburg","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0330","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/hmg\/ddh303","article-title":"van Gennip, beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities","volume":"13","author":"van Kuilenburg","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0335","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.molmed.2005.07.003","article-title":"Pyrimidine pathways in health and disease","volume":"11","author":"Loffler","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0340","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/154596830001400310","article-title":"Nifedipine and nimodipine competitively inhibit uridine kinase and orotidine-phosphate decarboxylase: theoretical relevance to poor outcome in stroke","volume":"14","author":"Najarian","year":"2000","journal-title":"Neurorehabil. Neural Repair"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0345","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1081\/NCN-200027624","article-title":"Pyrimidine degradation defects and severe 5-fluorouracil toxicity","volume":"23","author":"van Kuilenburg","year":"2004","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0350","series-title":"Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manua","first-page":"397","article-title":"Analysis of purines and pyrimidines in blood, urine and other physiological fluids","author":"Simmonds","year":"1991"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0355","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1373\/clinchem.2005.058842","article-title":"Comprehensive detection of disorders of purine and pyrimidine metabolism by HPLC with electrospray ionization tandem mass spectrometry","volume":"52","author":"Hartmann","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0360","series-title":"Laboratory Guide to the Methods in Biochemi- Cal Genetics","article-title":"Screening for disorders of purine and pyrimidine metabolism using HPLC-electrospray tandem mass spectrometry","author":"van Kuilenburg","year":"2008"},{"key":"10.1016\/j.ymgme.2022.02.007_bb0365","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/archdischild-2017-312738","article-title":"Diagnosing childhood-onset inborn errors of metabolism by next-generation sequencing","volume":"102","author":"Ghosh","year":"2017","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0370","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/s41436-020-0833-2","article-title":"Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy","volume":"22","author":"Del Cano-Ochoa","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2022.02.007_bb0375","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejpn.2015.11.012","article-title":"Role of reverse phenotyping in interpretation of next generation sequencing data and a review of INPP5E related disorders","volume":"20","author":"de Goede","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222001391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222001391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:52:11Z","timestamp":1761090731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719222001391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1096719222001391"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.02.007","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inborn errors of purine and pyrimidine metabolism: A guide to diagnosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}